NorthWest Biotherapeutics Inc (NWBO)

[eagle8]

Peter Davis
@peter_brit
#dcvax $nwbo #gbm

$nwbo has submitted additional information in relation to their combination patent (below):-

The additional information specifically references articles:-

"CTLA-4 Blockade in Tumor Models"

https://pmc.ncbi.nlm.nih.gov/articles/PMC3559193/



d_stock
@d_stock07734
·
2h
BMS has Ipilimumab and AZN has Tremelimumab. The two BPs would love to combine their CTLA4 inhibitors with DCVax-L.



and

"The effect of a Therapeutic Dendritic Cell-Based Cancer Vaccination Depends on the Blockage of CTLA-4 Signaling"

https://sciencedirect.com/science/article/abs/pii/S0304383505000972?via%3Dihub

18/489,222 | 2943-P91US.CON:

COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER :

https://patentcenter.uspto.gov/applications/18489222/ifw/docs?application=
Last edited
6:06 AM · Jan 23, 2025
·
338
Views